Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 study of Ginkgo Biloba for antidepressant-induced sexual dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba (Ginkgo biloba)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Hypoactive Sexual Desire Disorder, Sexual Dysfunctions, Psychological | Phase 2 | Status: COMPLETED